The real-world outcomes of multiple myeloma patients treated with daratumumab.
Most patients cannot be included in randomized clinical trials. We report real-world outcomes of all Danish patients with multiple myeloma (MM) treated with daratumumab-based regimens until 1 January 2019.<h4>Methods</h4>Information of 635 patients treated with daratumumab was collected...
Guardado en:
Autores principales: | Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Mette Bøegh Levring, Birgitte Preiss, Carsten Helleberg, Marie Fredslund Breinholt, Emil Hermansen, Lise Mette Rahbek Gjerdrum, Søren Thorgaard Bønløkke, Katrine Nielsen, Eigil Kjeldsen, Katrine Fladeland Iversen, Elena Manuela Teodorescu, Marveh Dokhi, Eva Kurt, Casper Strandholdt, Mette Klarskov Andersen, Annette Juul Vangsted |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a1957b6a5774014bba30b82888f0eeb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Factor structure of the parental reflective functioning questionnaire and association with maternal postpartum depression and comorbid symptoms of psychopathology.
por: Katrine I Wendelboe, et al.
Publicado: (2021) -
New developments in the treatment of multiple myeloma – clinical utility of daratumumab
por: McEllistrim C, et al.
Publicado: (2017) -
Daratumumab improves the anti-myeloma effect of newly emerging multidrug therapies
por: Gopalakrishnan S, et al.
Publicado: (2013) -
Glatte pornokroppe og alternative åbninger
por: Mette Grimstrup
Publicado: (2008) -
Vem tillhör tekniken?
por: Mette Bryld
Publicado: (2004)